Sodium oxybate
Sodium oxybate has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Oct 7, 2026: “Rapid Eye Movement Sleep Behavior Disorder as a Prodromal Manifestation of Alpha-Synucleinopathies”.
1 new paper in 30 daysSee all 1 papers on sodium oxybate
At a glance
40 trials, none about aging, 9 with no results posted.
- 40 trials, none about aging, 9 with no results posted
- 18 of 40 trials sponsored by its developers
Has sodium oxybate been tested in people?
0 of 40 about aging40 trials are registered, but no study of it in people has been published yet.
Approved
Jul 17, 2002Cataplexy, Narcolepsy, excessive daytime sleepiness
Oct 13, 2005Cataplexy, Narcolepsy
May 1, 2023Cataplexy, Narcolepsy, excessive daytime sleepiness
Repurposing
Phase 3Results posted4 trials
Phase 4Results posted1 trial
Phase 4Results posted1 trial
Phase 3Results posted5 trials
Phase 3Results posted3 trials
Phase 3Results posted3 trials
All 20Fewer
In trials
Sleep
Phase 4Completed1 trial
Disorders of Excessive Somnolence
Phase 3Results posted4 trials
Cluster Headache
Phase 3Status unknown1 trial
Stopped
NCT00706186Terminated
Withdrawn by Investigator, protocol in revision
Trial sponsors
Company11 trialsPhase 42,681 people
Company1 trialPhase 4314 people
Company1 trialPhase 44 people
Company2 trialsPhase 3220 people
Company1 trialPhase 125 people
2 trialsPhase 461 people
Universita Cattolica del Sacro Cuore
1 trialPhase 4127 people
St. Luke's Hospital, Chesterfield, Missouri
1 trialPhase 460 people